Josh Mandel-Brehm
Chief Executive Officer at CAMP4 Therapeutics Corporation
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2024
4 years of board service in total across 2 boards, counting each seat separately. Longest: ProMIS Neurosciences Inc., 2 years.
Chief executive roles
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
216.1% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | CAMP4 Therapeutics Corporation | Open-market purchase | +6,551 | $1.65 | $10,809 |
| Sep 11, 2025 | CAMP4 Therapeutics Corporation | Open-market purchase | +6,060 | $1.65 | $9,999 |
| Oct 15, 2024 | CAMP4 Therapeutics Corporation | Derivative conversion | +605 | — | — |
Questions about Josh Mandel-Brehm
What boards is Josh Mandel-Brehm on?
Josh Mandel-Brehm sits on the boards of CAMP4 Therapeutics Corporation and ProMIS Neurosciences Inc.
What company is Josh Mandel-Brehm the CEO of?
Josh Mandel-Brehm has been Chief Executive Officer of CAMP4 Therapeutics Corporation since October 2024.
How long has Josh Mandel-Brehm served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.